Northern Trust’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-197,896
| Closed | -$3.64M | – | 4536 |
|
|
2020
Q4 | $3.64M | Sell |
197,896
-12,567
| -6% | -$229K | ﹤0.01% | 2857 |
|
|
2020
Q3 | $3.86M | Buy |
210,463
+15,182
| +8% | +$255K | ﹤0.01% | 2698 |
|
|
2020
Q2 | $2.92M | Buy |
195,281
+27,894
| +17% | +$398K | ﹤0.01% | 2824 |
|
|
2020
Q1 | $2.65M | Buy |
167,387
+3,306
| +2% | +$53.4K | ﹤0.01% | 2689 |
|
|
2019
Q4 | $2.67M | Buy |
164,081
+3,806
| +2% | +$63.5K | ﹤0.01% | 2946 |
|
|
2019
Q3 | $2.38M | Sell |
160,275
-9,998
| -6% | -$135K | ﹤0.01% | 3006 |
|
|
2019
Q2 | $2.81M | Buy |
170,273
+8,101
| +5% | +$132K | ﹤0.01% | 2870 |
|
|
2019
Q1 | $2.81M | Buy |
162,172
+70
| +0% | +$1.27K | ﹤0.01% | 2883 |
|
|
2018
Q4 | $2.86M | Sell |
162,102
-2,213
| -1% | -$37.6K | ﹤0.01% | 2852 |
|
|
2018
Q3 | $2.98M | Buy |
164,315
+82,557
| +101% | +$1.69M | ﹤0.01% | 2988 |
|
|
2018
Q2 | $1.6M | Buy |
81,758
+43,778
| +115% | +$820K | ﹤0.01% | 3315 |
|
|
2018
Q1 | $667K | Buy |
37,980
+7,076
| +23% | +$130K | ﹤0.01% | 3494 |
|
|
2017
Q4 | $347K | Buy |
30,904
+868
| +3% | +$9.06K | ﹤0.01% | 3642 |
|
|
2017
Q3 | $320K | Hold |
30,036
| – | – | ﹤0.01% | 3659 |
|
|
2017
Q2 | $263K | Sell |
30,036
-102,447
| -77% | -$903K | ﹤0.01% | 3713 |
|
|
2017
Q1 | $1.56M | Sell |
132,483
-829
| -0.6% | -$10.1K | ﹤0.01% | 3192 |
|
|
2016
Q4 | $1.75M | Sell |
133,312
-2,247
| -2% | -$30.1K | ﹤0.01% | 3163 |
|
|
2016
Q3 | $1.97M | Buy |
135,559
+493
| +0.4% | +$7K | ﹤0.01% | 3081 |
|
|
2016
Q2 | $1.62M | Buy |
135,066
+17,081
| +14% | +$274K | ﹤0.01% | 3153 |
|
|
2016
Q1 | $2.2M | Buy |
117,985
+5,017
| +4% | +$83.2K | ﹤0.01% | 2930 |
|
|
2015
Q4 | $2.43M | Buy |
112,968
+1,237
| +1% | +$26.1K | ﹤0.01% | 2943 |
|
|
2015
Q3 | $1.89M | Buy |
111,731
+85,480
| +326% | +$2.13M | ﹤0.01% | 3085 |
|
|
2015
Q2 | $985K | Buy |
26,251
+16,832
| +179% | +$543K | ﹤0.01% | 3353 |
|
|
2015
Q1 | $296K | Buy |
+9,419
| New | +$255K | ﹤0.01% | 3759 |
|
Northern Trust's CBMG Position: Q1 2021 in Review
Northern Trust sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 197,896 shares — an estimated $3.64M sold.
Northern Trust first reported a position in CBMG in Q1 2015 and held it in 24 quarters. The position peaked at $3.86M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- Northern Trust reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- Northern Trust sold 197,896 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $3.64M.
- Northern Trust first reported a position in Cellular Biomedicine Group, Inc. in Q1 2015 and held it in 24 quarters.
- Northern Trust's Cellular Biomedicine Group, Inc. position peaked at $3.86M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.